Provided by Tiger Fintech (Singapore) Pte. Ltd.

Mirum Pharmaceuticals, Inc.

42.03
-1.2000-2.78%
Post-market: 42.030.00000.00%17:11 EDT
Volume:641.60K
Turnover:26.95M
Market Cap:2.06B
PE:-22.71
High:43.03
Open:42.15
Low:41.31
Close:43.23
Loading ...

Analysts Are Bullish on These Healthcare Stocks: Annexon Biosciences (ANNX), Mirum Pharmaceuticals (MIRM)

TIPRANKS
·
21 Nov 2024

Analysts Are Updating Their Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) Estimates After Its Third-Quarter Results

Simply Wall St.
·
15 Nov 2024

Mirum Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations

Simply Wall St.
·
14 Nov 2024

Mirum Pharmaceuticals Price Target Maintained With a $66.00/Share by HC Wainwright & Co.

Dow Jones
·
14 Nov 2024

Mirum Pharmaceuticals Inc : Leerink Partners Raises Target Price to $50 From $49

THOMSON REUTERS
·
13 Nov 2024

Mirum Pharmaceuticals Is Maintained at Outperform by Baird

Dow Jones
·
13 Nov 2024

Mirum Pharmaceuticals Inc : Morgan Stanley Raises Target Price to $60 From $59

THOMSON REUTERS
·
13 Nov 2024

Mirum Pharmaceuticals Inc (MIRM) Q3 2024 Earnings Call Highlights: Record Sales Surge and ...

GuruFocus.com
·
13 Nov 2024

Mirum Pharmaceuticals Inc : Baird Raises Target Price to $50 From $44

THOMSON REUTERS
·
13 Nov 2024

Mirum's Q3 Earnings Beat Estimates, 2024 Revenue View Raised

Zacks
·
13 Nov 2024

Mirum Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
12 Nov 2024

BUZZ-Mirum rises on 2024 revenue forecast raise

Reuters
·
12 Nov 2024

Mirum Pharmaceuticals, Inc. (MIRM) Reports Q3 Loss, Tops Revenue Estimates

Zacks
·
12 Nov 2024

Mirum Pharmaceuticals' Q3 Loss Narrows, Revenue Rises

MT Newswires Live
·
12 Nov 2024

Mirum Pharmaceuticals Q3 2024 GAAP EPS $(0.30) Beats $(0.44) Estimate, Sales $90.30M Beat $82.02M Estimate

Benzinga
·
12 Nov 2024

Mirum Pharmaceuticals: Global Net Product Sales 2024 Guidance Increased to $330 Mln - $335 Mln

THOMSON REUTERS
·
12 Nov 2024

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

THOMSON REUTERS
·
09 Nov 2024

Mirum Pharmaceuticals Inc expected to post a loss of 45 cents a share - Earnings Preview

Reuters
·
08 Nov 2024

High Growth Tech Stocks In The United States To Watch

Simply Wall St.
·
07 Nov 2024

Is Mirum Pharmaceuticals (NASDAQ:MIRM) Using Too Much Debt?

Simply Wall St.
·
03 Nov 2024